Combination of Daratumumab and BD Regimen and Dapagliflozin in the Treatment of M-protein Related Cardiac Disease

Conditions: M-protein Related Cardiac Disease Interventions: Drug: Daratumumab + Bortezomib + Dexamethasone + Dapagliflozin Sponsors: Beijing Chao Yang Hospital; Beijing Chuiyangliu Hospital; Beijing Boren Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials